Patrick Thomas McGann MD MS
Pediatric Anemia and Red Blood Cell Hematology, Pediatric Platelet Disorder Hematology
Associate Professor of Pediatrics
Join to View Full Profile
593 Eddy StProvidence, RI 02903
Phone+1 401-444-6195
Dr. McGann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineMS, Clinical Investigation, 2011 - 2013
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2012
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2009 - 2011
Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 2006 - 2009
Tufts University School of MedicineClass of 2006
Certifications & Licensure
RI State Medical License 2021 - 2026
OH State Medical License 2014 - 2022
TX State Medical License 2012 - 2015
TN State Medical License 2009 - 2012
MA State Medical License 2008 - 2009
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Hydroxyurea Optimization Through Precision Study Start of enrollment: 2019 Jan 17
Roles: Contact
Publications & Presentations
PubMed
- How We Approach Contraception for Adolescents and Young Adults With Sickle Cell Disease.Maayan Leroy-Melamed, Patrick McGann, Layla Van Doren
Pediatric Blood & Cancer. 2025-06-01 - Sickle cell trait does not cause "sickle cell crisis" leading to exertion-related death: a systematic review.Lachelle D Weeks, Allecia M Wilson, Rakhi P Naik, Yvonne Efebera, M Hassan Murad
Blood. 2025-03-27 - Accelerated Drug Approvals and Patient Trust: Impact of Voxelotor & Crizanlizumab for Sickle Cell Disease.Kristine Anne Karkoska, Seethal A Jacob, Patrick T McGann
Blood Advances. 2025-03-14
Press Mentions
Lifespan Gets $1 Million to Improve Sickle Cell CareSeptember 30th, 2024
Grant Support
- Promoting Utilization and Safety of Hydroxyurea Using Precision in AfricaRHODE ISLAND HOSPITAL2021–2026
- Mobile phone-based screening for anemia in young children in western KenyaRHODE ISLAND HOSPITAL2023–2025
- Developmental Pharmacology of Hydroxyurea Across the Age Span for the Treatment of Sickle Cell AnemiaRHODE ISLAND HOSPITAL2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
